Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and

This topic has 0 replies, 1 voice, and was last updated 12 years, 9 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
October 7, 2011 at 12:56 pm #5754

gavin
Moderator

Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin.

http://adisonline.com/biodrugs/Abstract/2011/25050/Advances_in_Liver_Cancer_Antibody_Therapies__A.1.aspx
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘New Developments’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation